Psoriasis biologics: a new era of choice

Lancet. 2019 Sep 7;394(10201):807-808. doi: 10.1016/S0140-6736(19)31772-6. Epub 2019 Aug 8.

Authors

Satveer K Mahil¹, Catherine H Smith²

Affiliations

¹ St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London SE1 9RT, UK. Electronic address: [email protected].
² St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London SE1 9RT, UK.

PMID: 31402113
DOI: 10.1016/S0140-6736(19)31772-6

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Biological Products*
Humans
Psoriasis*

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Biological Products
guselkumab
secukinumab